HomeGLUE • NASDAQ
add
Monte Rosa Therapeutics Inc
Previous close
$3.87
Day range
$3.81 - $4.05
Year range
$3.21 - $12.40
Market cap
244.81M USD
Avg Volume
674.02K
P/E ratio
321.23
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 84.93M | 7,882.05% |
Operating expense | 40.89M | 13.56% |
Net income | 46.88M | 246.66% |
Net profit margin | 55.20 | 101.84% |
Earnings per share | 0.57 | 207.55% |
EBITDA | 46.08M | 239.44% |
Effective tax rate | 1.72% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 326.07M | 69.04% |
Total assets | 393.20M | 47.41% |
Total liabilities | 118.04M | 3.34% |
Total equity | 275.16M | — |
Shares outstanding | 61.51M | — |
Price to book | 0.87 | — |
Return on assets | 26.47% | — |
Return on capital | 37.79% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 46.88M | 246.66% |
Cash from operations | -45.49M | -19.20% |
Cash from investing | -100.23M | -1,117.24% |
Cash from financing | 14.00K | -94.31% |
Net change in cash | -145.71M | -419.16% |
Free cash flow | -64.91M | -176.43% |
About
Founded
2019
Headquarters
Website
Employees
142
